Rhythm Pharmaceuticals (RYTM) Return on Invested Capital (2025 - 2026)
Rhythm Pharmaceuticals' (RYTM) quarterly Return on Invested Capital came in at 0.09% in Q1 2026, up 65.0% year-on-year from 0.05% in Q1 2025, and up 29.74% on a QoQ basis from 0.13% in Q4 2025.
Rhythm Pharmaceuticals (RYTM) Return on Invested Capital (2025 - 2026) Analysis & Trends
Rhythm Pharmaceuticals (RYTM) has 2 years of Return on Invested Capital data on file, last reported at 0.09% in Q1 2026.
- On a quarterly basis, Return on Invested Capital rose 65.0% year-over-year to 0.09% in Q1 2026; TTM through Mar 2026 was 0.09%, a 65.0% increase from a year earlier, with the FY2025 full-year figure at 0.44%, changed N/A from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.09%, up from 0.13% in the prior quarter.
- Over the last five years, Return on Invested Capital for RYTM reached as high as 0.09% in Q1 2026 and fell as low as 0.74% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Rhythm Pharmaceuticals | 6.98 Bn | 6.64 Bn | 52.96 Mn | -0.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.09% |
| Dec 31, 2025 | -0.13% |
| Sep 30, 2025 | -0.19% |
| Jun 30, 2025 | -0.35% |
| Mar 31, 2025 | -0.74% |